Authors:
Ruzicka, K
Veitl, M
Thalhammer-Scherrer, R
Schwarzinger, I
Citation: K. Ruzicka et al., The new hematology analyzer Sysmex XE-2100 - Performance evaluation of a novel white blood cell differential technology, ARCH PATH L, 125(3), 2001, pp. 391-396
Authors:
Thalhammer-Scherrer, R
Veitl, M
Exner, M
Schneider, B
Geissler, K
Simonitsch, I
Schwarzinger, I
Citation: R. Thalhammer-scherrer et al., Role of immunological lymphocyte subset typing as a screening method for lymphoid malignancies in daily routine practice, CYTOMETRY, 42(1), 2000, pp. 5-10
Authors:
Hamwi, A
Veitl, M
Maenner, G
Vogelsang, H
Szekeres, T
Citation: A. Hamwi et al., Pancreatic elastase 1 in stool: Variations within one stool passage and individual changes from day to day, WIEN KLIN W, 112(1), 2000, pp. 32-35
Authors:
Hamwi, A
Veitl, M
Manner, G
Ruzicka, K
Schweiger, C
Szekeres, T
Citation: A. Hamwi et al., Evaluation of four automated methods for determination of whole blood cyclosporine concentrations, AM J CLIN P, 112(3), 1999, pp. 358-365
Authors:
Gasic, S
Wagner, OF
Fasching, P
Ludwig, C
Veitl, M
Kapiotis, S
Jilma, B
Citation: S. Gasic et al., Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria, AM J HYPERT, 12(2), 1999, pp. 217-222
Citation: Sa. Umpleby et M. Veitl, Special issue: Papers from the 1997 Meeting of the American Society for Cybernetics (Part II), CYBERN SYST, 30(4), 1999, pp. 295-296
Citation: S. Umpleby et M. Veitl, Special issue, papers from the 1997 meeting of the American Society for Cybernetics (part I), CYBERN SYST, 30(2), 1999, pp. 77-78
Authors:
Hamwi, A
Eppel, W
Berger, A
Veitl, M
Vukovich, T
Bieglmayer, C
Citation: A. Hamwi et al., Is there a diagnostic ranking of creatine kinase isoenzymes in the female reproductive tract in case of ectopic pregnancy?, GEBURTSH FR, 59(3), 1999, pp. 107-110
Authors:
Locker, GJ
Kapiotis, S
Veitl, M
Mader, RM
Stoiser, B
Kofler, J
Sieder, AE
Rainer, H
Steger, GG
Mannhalter, C
Wagner, OF
Citation: Gj. Locker et al., Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disorders, BR J HAEM, 105(4), 1999, pp. 912-919